Oxford Biomedica PLC — Director's Dealing 2014

Dec 16, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9307Z

Oxford Biomedica PLC

16 December 2014

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

1	Issuer	Oxford BioMedica PLC
2	Reason for notification	Notification relates to DTR 3.1.2R
3	Name of PDMR	Martin Diggle
4	Connected person	Notification relates to following connected persons: Vulpes Testudo Fund Vulpes Life Sciences Fund
5	Notification in respect of	Notification in respect of holdings of persons in 4 above
6	Description of shares	Oxford BioMedica PLC ordinary shares of 1p each
7	Name of registered shareholders and number of shares	Vulpes Testudo Fund - 85,797,333 shares Vulpes Life Sciences Fund - 447,452,767 shares
8	Nature of transaction	Disposal
9	Number of shares acquired	N/A
10	Percentage of issued class acquired	N/A
11	Shares disposed	Vulpes Testudo Fund - 85,797,333 shares
12	Percentage of issued class disposed	Vulpes Testudo Fund - 3.34%
13/14	Price per share of transactions, and date	Vulpes Testudo Fund 85,797,333 shares @ £0.05 , 12 December 2014
15	Total holding following notification and total percentage holding following notification	Vulpes Life Sciences Fund - 447,452,767 shares 17.44%
16	Date issuer informed	12 December 2014
23	Any additional information	None
24	Contact name and telephone number	T. Watts, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBSBDDSXBBGSL